Lyell Immunopharma, Inc. - LYEL

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$308.5M

QoQ value delta ($000)

-$63.94M (-17.17%)

Implied price effect (QoQ)

-30.91%

Total shares

14,537,209

QoQ shares delta

+2,411,432 (+19.89%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 76 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
ARCH Venture Management, LLC	65,138	3,247,162	9.62%
MWG Caph Ltd	31,029	1,008,116	42.88%
GSK plc	30,343	1,512,659	5.06%
VANGUARD GROUP INC	25,437	826,430	0.0%
Foresite Capital Management IV, LLC	16,056	800,399	6.77%
Orland Properties Ltd	15,139	754,698	5.67%
VANGUARD CAPITAL MANAGEMENT LLC	14,406	718,155	0.0%
Decheng Capital LLC	13,882	692,050	2.1%
Almitas Capital LLC	11,590	577,807	2.62%
Foresite Capital Management V, LLC	9,570	477,078	3.53%
MILLENNIUM MANAGEMENT LLC	9,205	458,905	0.0%
CITADEL ADVISORS LLC	7,892	393,462	0.0%
venBio Partners LLC	6,774	337,697	2.41%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	6,222	310,198	0.0%
Alphabet Inc.	5,882	293,256	0.15%
BlackRock, Inc.	3,847	191,820	0.0%
GEODE CAPITAL MANAGEMENT, LLC	3,351	166,980	0.0%
MARSHALL WACE, LLP	2,979	148,516	0.0%
RENAISSANCE TECHNOLOGIES LLC	2,335	116,411	0.0%
GOLDMAN SACHS GROUP INC	2,296	114,491	0.0%
Velan Capital Investment Management LP	2,046	102,000	1.28%
MIC Capital Management UK LLP	1,745	87,028	0.5%
VANGUARD FIDUCIARY TRUST CO	1,743	86,925	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1,724	85,971	0.0%
Opaleye Management Inc.	1,586	79,097	0.21%